Quibim, S.L | MRI-based automatic quantitative evaluation tool (prostate, brain, liver)CT-based automatic quantitative evaluation tool (lung)

Quibim, S.L

Brief Product Description
MRI-based automatic quantitative evaluation tool (prostate, brain, liver)
CT-based automatic quantitative evaluation tool (lung)

Technology
Prostate cancer, neurodegenerative diseases, chronic liver disease, lung cancer

Automated quantitative MRI analysis tools for:
– segmenting the prostate gland, detecting significant prostate cancer lesions, and reporting adhering to PI-RADS2.1 guidelines,
– automated quantitative analysis of brain structure volumes and white matter hyperintensities load/location and radiological reporting,
– quantification of tissue fat and iron of liver enabling comprehensive steatosis and iron overload evaluation, and liver segmentation
 
Automated quantitative CT image analysis tool for:
– automated lung lesions segmentation and tumor characterization.

This field is for validation purposes and should be left unchanged.
*If you have set up domain rejection, please check your email receiving settings to allow emails from [@micron-kobe.com].
Micron Updates
ConfirmationRequired

Please feel free to contact us

We provide comprehensive, end‑to‑end clinical development support, with imaging at its core.

With more than 20 years of experience, our team of imaging specialists in Japan and around the world tackles the complex challenges of imaging evaluation in pharmaceutical and medical device development. We deliver optimal, project‑specific solutions for each client.